207 related articles for article (PubMed ID: 27221238)
21. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
22. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark.
Kjaer SK; Breugelmans G; Munk C; Junge J; Watson M; Iftner T
Int J Cancer; 2008 Oct; 123(8):1864-70. PubMed ID: 18661520
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
24. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
26. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
[TBL] [Abstract][Full Text] [Related]
27. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
Franceschi S; Chantal Umulisa M; Tshomo U; Gheit T; Baussano I; Tenet V; Tshokey T; Gatera M; Ngabo F; Van Damme P; Snijders PJ; Tommasino M; Vorsters A; Clifford GM
Int J Cancer; 2016 Aug; 139(3):518-26. PubMed ID: 26991686
[TBL] [Abstract][Full Text] [Related]
28. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
Otero-Motta AP; Ordóñez JL; González-Celador R; Rivas B; Macías Mdel C; Bullón A; Abad Mdel M
APMIS; 2011 Mar; 119(3):204-15. PubMed ID: 21284738
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women.
Shiko Y; Konno R; Konishi H; Sauvaget C; Ohashi Y; Kakizoe T
BMC Infect Dis; 2020 Nov; 20(1):808. PubMed ID: 33153446
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
Six L; Leodolter S; Sings HL; Barr E; Haupt R; Joura EA
Wien Klin Wochenschr; 2008; 120(21-22):666-71. PubMed ID: 19116707
[TBL] [Abstract][Full Text] [Related]
33. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
Kjær SK; Munk C; Junge J; Iftner T
Cancer Causes Control; 2014 Feb; 25(2):179-89. PubMed ID: 24242002
[TBL] [Abstract][Full Text] [Related]
34. Effect of human papilloma virus vaccination on sexual behaviours among adolescent women in Rwanda: a regression discontinuity study.
Hategeka C; Ogilvie G; Nisingizwe MP; Rulisa S; Law MR
Health Policy Plan; 2020 Oct; 35(8):1021-1028. PubMed ID: 32830261
[TBL] [Abstract][Full Text] [Related]
35. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study.
Guettiti H; Ennaifer E; Attia L; Chelly D; Alaya NB; Aissa RB; Laassili T; Boubaker S
Asian Pac J Cancer Prev; 2014; 15(21):9361-5. PubMed ID: 25422225
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
37. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
[TBL] [Abstract][Full Text] [Related]
38. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
Mchome BL; Kjaer SK; Manongi R; Swai P; Waldstroem M; Iftner T; Wu C; Mwaiselage J; Rasch V
Sex Transm Infect; 2021 Feb; 97(1):56-62. PubMed ID: 32269071
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies.
Wei F; Gaisa MM; D'Souza G; Xia N; Giuliano AR; Hawes SE; Gao L; Cheng SH; Donà MG; Goldstone SE; Schim van der Loeff MF; Neukam K; Meites E; Poynten IM; Dai J; Combes JD; Wieland U; Burgos J; Wilkin TJ; Hernandez AL; Iribarren Díaz M; Hidalgo-Tenorio C; Valencia Arredondo M; Nyitray AG; Wentzensen N; Chow EP; Smelov V; Nowak RG; Phanuphak N; Woo YL; Choi Y; Hu Y; Schofield AM; Woestenberg PJ; Chikandiwa AT; Hickey AC; de Pokomandy A; Murenzi G; Péré H; Del Pino M; Ortiz AP; Charnot-Katsikas A; Liu X; Chariyalertsak S; Strong C; Ong JJ; Yunihastuti E; Etienney I; Ferré VM; Zou H; Segondy M; Chinyowa S; Alberts CJ; Clifford GM
Lancet HIV; 2021 Sep; 8(9):e531-e543. PubMed ID: 34339628
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus types among women infected with HIV: a meta-analysis.
Clifford GM; Gonçalves MA; Franceschi S;
AIDS; 2006 Nov; 20(18):2337-44. PubMed ID: 17117020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
